Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 5—May 2025
Synopsis
Comprehensive Survival Analysis of Alveolar Echinococcosis Patients, University Hospital Zurich, Zurich, Switzerland, 1973–2022
Ansgar Deibel1
, Yanick Kindler1, Rubens Mita, Soleen Ghafoor, Cordula Meyer zu Schwabedissen, Barbara Brunner-Geissmann, Alexander Schweiger, Felix Grimm, Michael Reinehr, Achim Weber, Cäcilia S. Reiner, Andreas E. Kremer, Henrik Petrowsky, Pierre-Alain Clavien, Peter Deplazes, Stefanie von Felten, and Beat Müllhaupt
, Yanick Kindler1, Rubens Mita, Soleen Ghafoor, Cordula Meyer zu Schwabedissen, Barbara Brunner-Geissmann, Alexander Schweiger, Felix Grimm, Michael Reinehr, Achim Weber, Cäcilia S. Reiner, Andreas E. Kremer, Henrik Petrowsky, Pierre-Alain Clavien, Peter Deplazes, Stefanie von Felten, and Beat Müllhaupt
Table 2
Treatments used for alveolar echinococcosis patients, University Hospital Zurich, Zurich, Switzerland, 1973–2022*
| Treatment | Value |
|---|---|
| No. patients | 334 |
| Surgical therapy | 151 (45.2) |
| Time to surgery, mo, median (IQR) | 1 (0–4) |
| Surgery aim | |
| Palliative | 25 (7.5) |
| After >12 mo | 5 (1.5) |
| Curative | 126 (37.7) |
| after >12 mo | 5 (1.5) |
| Resection margins | |
| R0 | 105 (31.4) |
| R1 | 21 (6.3) |
| Surgery type | |
| Segmentectomy | 51 (15.3) |
| Hemihepatectomy | 53 (15.9) |
| Extended hemihepatectomy | 17 (5.1) |
| Liver transplantation | 3 (0.9) |
| Nonhepatic surgery | 2 (0.6) |
| Benzimidazole drug therapy | 315 (94.3) |
| Time to benzimidazole start, mo, median (IQR) | 1 (0–2) |
| >12 mo | 17 (5.1) |
| Benzimidazole drug type | |
| Albendazole | 241 (72.2) |
| Mebendazole | 74 (22.2) |
| Clinical setting | |
| After curatively intended surgery | 122 (36.5) |
| R0 margin | 97 (29.0) |
| Duration, mo, median (IQR) | 26 (23–31.5) |
| R1 margin | 21 (6.3) |
| Duration, mo, median (IQR) | 79 (44–152) |
| Palliative surgery and nonresected | 212 (63.5) |
*Values are no. (%) except as indicated.
1These first authors contributed equally to this article.
Page created: March 11, 2025
Page updated: April 22, 2025
Page reviewed: April 22, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.